# Phase 1/2 Study TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer

> clinical trial · VERIFIED · 2026-06-11

Status: RECRUITING · Sponsor: M.D. Anderson Cancer Center · Condition: Pancreatic Cancer

- Company: M.D. Anderson Cancer Center
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07377526

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.